14 patents
Utility
Lipids As Synthetic Vectors to Enhance Antigen Processing and Presentation Ex-vivo In Dendritic Cell Therapy
14 Sep 23
The invention covers the use of certain classes of lipids including cationic lipids in ex-vivo dendritic cell therapies.
Frank Bedu-Addo, Greg Conn, Siva K. Gandhapudi, Martin Ward, Jerold Woodward
Filed: 27 Apr 23
Utility
Methods to Alter the Tumor Microenvironment for Effective Cancer Immunotherapy
16 Feb 23
Methods and compositions for altering the microenvironment of a tumor are provided.
Frank Bedu-Addo, Greg Conn, Siva K. Gandhapudi, Martin Ward, Jerold Woodward
Filed: 24 Aug 22
Utility
Novel HPV16 Non Hla-restricted T-cell Vaccines, Compositions and Methods of Use Thereof
20 Oct 22
Novel human papillomovirus immunogenic compositions and methods of use thereof are provided.
Frank Bedu-Addo, Greg Conn, Martin Ward, Jerold Woodward
Filed: 30 Jun 22
Utility
Methods and Compositions Comprising Cationic Lipids for Immunotherapy by Direct Tumor Injection
26 May 22
Provided herein are novel immunotherapeutic interventions comprising the use of cationic lipid-based compositions for direct tumor injection.
Frank Bedu-Addo, Greg Conn, Martin Ward, Jerold Woodward, Siva K. Gandhapudi
Filed: 22 Nov 21
Utility
Stimulation of an Immune Response by Cationic Lipids
3 Feb 22
The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antigens.
Weihsu Chen, Weili Yan, Kenya Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
Filed: 22 Jul 21
Utility
Vaccine Compositions and Methods of Use
25 Nov 21
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid.
Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
Filed: 22 Jul 21
Utility
Stimulation of an Immune Response by Cationic Lipids
11 Nov 21
The present invention provides compositions and methods for stimulating an immune response using cationic lipids alone or in combination with antiigens.
Weihsu Chen, Weili Yan, Kenya Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
Filed: 22 Jul 21
Utility
Cationic Lipid Vaccine Compositions and Methods of Use
11 Nov 21
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor.
Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
Filed: 22 Jul 21
Utility
Stimulation of an Immune Response by Enantiomers of Cationic Lipids
7 Oct 21
A composition and method for activating immune cells ex-vivo, or inducing an immune response in a subject including a composition comprising at least one chiral cationic lipid.
Elizabeth Ann Vasievich, Weihsu Claire Chen, Kenya N. Toney Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
Filed: 25 Mar 21
Utility
Cationic Lipid Vaccine Compositions and Methods of Use
8 Apr 21
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor.
Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
Filed: 1 Oct 20
Utility
Stimulation of an Immune Response by Enantiomers of Cationic Lipids
21 Oct 20
A composition and method for activating immune cells ex-vivo, or inducing an immune response in a subject including a composition comprising at least one chiral cationic lipid.
Elizabeth Ann Vasievich, Weihsu Claire Chen, Kenya N. Toney Johnson, Gregory Conn, Frank Bedu-Addo, Leaf Huang
Filed: 11 Jun 20
Utility
Cationic Lipid Vaccine Compositions and Methods of Use
11 Dec 19
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor.
Kenya Johnson, Eric Jacobson, Frank Bedu-Addo, Mikayel Mkrtichyan, Samir N. Khleif
Filed: 27 Mar 19
Utility
Improved Vaccine Compositions and Methods of Use
27 Nov 19
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one antigen, wherein the adjuvant is a cationic lipid.
Frank Bedu-Addo, Eric Jacobson, Kenya Johnson
Filed: 17 Apr 19
Utility
Lipids As Synthetic Vectors to Enhance Antigen Processing and Presentation Ex-vivo In Dendritic Cell Therapy
27 Nov 19
The invention covers the use of certain classes of lipids including cationic lipids in ex-vivo dendritic cell therapies.
Frank Bedu-Addo, Greg Conn, Siva K. Gandhapudi, Martin Ward, Jerold Woodward
Filed: 5 Aug 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first